Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Formularies as Topic”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,027 records · Page 57Linked to original sources
PubMedDate not supplied

Electronic prescribing: a review of costs and benefits.

Electronic prescribing tools are currently available but most medical practices are not using them. The literature was reviewed for data on adverse drug events and the expected dollar savings that could occur if these events were prevented. In addition to cost savings from improved patient safety, the effect of these systems on formulary compliance and drug cost savings was examined. Improved physician, nurse, and staff efficiencies were calculated using time trial comparisons between a paper system of handling prescription refills and a representative electronic prescribing system. The conclusion is made that electronic prescribing software is cost-effective for all size practices with a more rapid return on investment in larger practices.

Adverse Drug Reaction Reporting Systems↗
PubMed2003

Medicaid prescription drug coverage: state efforts to control costs.

This paper provides a brief summary of the Medicaid prescription drug benefit. It explains the mechanisms being used by states to control their prescription drug spending within the Medicaid program. The paper also highlights some of the concerns that have been expressed with these mechanisms and the litigation that has been initiated in several states as a result of these efforts. It takes a closer look at three states with cost-containment strategies that have been the focus of increased scrutiny.

Cost Control↗
PubMed2003

Developing a management plan.

Many complex issues are associated with specialty pharmaceuticals in the development of a successful specialty pharmaceutical program. A previous article focused on the definition and scope of specialty pharmaceuticals. This article explores the mechanics of developing and managing a specialty pharmaceutical program, specifically, authorization management.

Biotechnology↗
PubMed2003

Do consumers' attitudes predict prescription purchasing behavior?

Consumers may face prescription choices in three-tier plans, primarily between lower-cost generic drugs, formulary (tier 2) brands, and higher-cost nonformulary (tier 3) brands. To determine if consumers' beliefs about medications influence their prescription choices, a preliminary evaluation of the effect of such beliefs on prescription purchasing behavior was conducted in an MCO population. Attitudes about prescription drug coverage and perceptions regarding medications had no demonstrated effect on formulary compliance or rates of discontinuation of nonformulary medications. The findings appear to support the concept of three-tier plans, and increasing copayments seems to facilitate greater adherence to health plan formularies.

Adolescent↗
PubMed2003

States handle shortfall in a variety of ways. Everyone reports higher costs, uncertainty ahead.

States across the nation are gearing up for a cold fall and winter when it comes to funding for ADAPs. The reality is that many states only can afford to assist a portion of those people in need. That could result in states taking several cost-saving measures, such as capping enrollment, starting wait lists, reducing formularies, requiring generic drugs, cutting additional health care services, and other strategies.

Anti-HIV Agents↗